Gena Wang
Stock Analyst at Barclays
(3.63)
# 2,138
Out of 4,509 analysts
743
Total ratings
44.1%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Gena Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Initiated Coverage: Buy | $8 → $9 | $2.90 | +210.34% | 15 | May 28, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $71 → $87 | $82.24 | +5.79% | 5 | Dec 21, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $81 → $50 | $33.22 | +50.51% | 42 | Nov 24, 2025 | |
| MRNA Moderna | Maintained: Hold | $25 | $67.01 | -62.69% | 31 | Nov 21, 2025 | |
| KOD Kodiak Sciences | Maintained: Hold | $17 | $41.10 | -58.64% | 27 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintained: Buy | $94 → $90 | $25.75 | +249.51% | 27 | Nov 13, 2025 | |
| EDIT Editas Medicine | Maintained: Hold | $3 | $3.16 | -5.06% | 31 | Nov 11, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintained: Hold | $56 | $50.63 | +10.61% | 27 | Nov 11, 2025 | |
| VIR Vir Biotechnology | Maintained: Buy | $31 | $9.72 | +218.93% | 24 | Nov 11, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | $414 | $480.25 | -13.79% | 36 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $11.30 | +192.04% | 12 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.073 | +1,269.86% | 27 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 | $8.08 | -75.25% | 22 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $12.75 | +190.20% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $385 | $303.96 | +26.66% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $14 | $13.02 | +7.53% | 33 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $20 | $18.82 | +6.27% | 64 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $68 | $81.33 | -16.39% | 51 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $31.00 | -32.26% | 22 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $9 | $9.91 | -9.18% | 26 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $9.72 | -7.41% | 19 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 → $527 | $288.06 | +82.95% | 55 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $95 | $56.75 | +67.40% | 30 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $80 | $59.20 | +35.14% | 35 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 → $62 | $12.22 | +407.36% | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 → $48 | $34.34 | n/a | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $24.94 | n/a | 13 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $16 → $25 | $6.71 | n/a | 12 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $18 | $12.34 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $6 | $8.59 | n/a | 3 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $21 | $56.29 | n/a | 3 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $21 | $76.11 | n/a | 7 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $8.67 | n/a | 5 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.01 | n/a | 1 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $663.09 | n/a | 1 | Aug 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $24.48 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $41.10 | n/a | 1 | Jul 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $56 | $0.9835 | n/a | 2 | Mar 17, 2015 |
Cellectis
May 28, 2026
Initiated Coverage: Buy
Price Target: $8 → $9
Current: $2.90
Upside: +210.34%
Cytokinetics
Dec 21, 2025
Maintained: Buy
Price Target: $71 → $87
Current: $82.24
Upside: +5.79%
Ultragenyx Pharmaceutical
Nov 24, 2025
Maintained: Buy
Price Target: $81 → $50
Current: $33.22
Upside: +50.51%
Moderna
Nov 21, 2025
Maintained: Hold
Price Target: $25
Current: $67.01
Upside: -62.69%
Kodiak Sciences
Nov 17, 2025
Maintained: Hold
Price Target: $17
Current: $41.10
Upside: -58.64%
Legend Biotech
Nov 13, 2025
Maintained: Buy
Price Target: $94 → $90
Current: $25.75
Upside: +249.51%
Editas Medicine
Nov 11, 2025
Maintained: Hold
Price Target: $3
Current: $3.16
Upside: -5.06%
CRISPR Therapeutics AG
Nov 11, 2025
Maintained: Hold
Price Target: $56
Current: $50.63
Upside: +10.61%
Vir Biotechnology
Nov 11, 2025
Maintained: Buy
Price Target: $31
Current: $9.72
Upside: +218.93%
Vertex Pharmaceuticals
Nov 10, 2025
Maintained: Hold
Price Target: $414
Current: $480.25
Upside: -13.79%
Nov 10, 2025
Maintained: Buy
Price Target: $38 → $33
Current: $11.30
Upside: +192.04%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $1
Current: $0.073
Upside: +1,269.86%
Nov 7, 2025
Maintained: Sell
Price Target: $2
Current: $8.08
Upside: -75.25%
Nov 7, 2025
Maintained: Buy
Price Target: $37
Current: $12.75
Upside: +190.20%
Nov 7, 2025
Maintained: Buy
Price Target: $385
Current: $303.96
Upside: +26.66%
Nov 7, 2025
Maintained: Buy
Price Target: $24 → $14
Current: $13.02
Upside: +7.53%
Nov 5, 2025
Maintained: Hold
Price Target: $22 → $20
Current: $18.82
Upside: +6.27%
Nov 5, 2025
Maintained: Hold
Price Target: $46 → $68
Current: $81.33
Upside: -16.39%
Nov 5, 2025
Maintained: Hold
Price Target: $21
Current: $31.00
Upside: -32.26%
Nov 3, 2025
Maintained: Hold
Price Target: $11 → $9
Current: $9.91
Upside: -9.18%
Nov 3, 2025
Maintained: Buy
Price Target: $10 → $9
Current: $9.72
Upside: -7.41%
Oct 31, 2025
Maintained: Buy
Price Target: $460 → $527
Current: $288.06
Upside: +82.95%
Oct 30, 2025
Maintained: Buy
Price Target: $80 → $95
Current: $56.75
Upside: +67.40%
Oct 28, 2025
Maintained: Buy
Price Target: $86 → $80
Current: $59.20
Upside: +35.14%
Aug 7, 2025
Maintained: Buy
Price Target: $59 → $62
Current: $12.22
Upside: +407.36%
Aug 10, 2023
Rated: Buy
Price Target: $4 → $48
Current: $34.34
Upside: n/a
Dec 22, 2022
Maintained: Hold
Price Target: $7 → $9
Current: $24.94
Upside: n/a
Nov 2, 2022
Upgraded: Hold
Price Target: $16 → $25
Current: $6.71
Upside: n/a
May 13, 2022
Maintained: Buy
Price Target: $32 → $18
Current: $12.34
Upside: n/a
Mar 15, 2022
Maintained: Buy
Price Target: $18 → $6
Current: $8.59
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $19 → $21
Current: $56.29
Upside: n/a
May 12, 2020
Maintained: Hold
Price Target: $20 → $21
Current: $76.11
Upside: n/a
Jun 22, 2017
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $8.67
Upside: n/a
Jan 20, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $7.01
Upside: n/a
Aug 17, 2016
Reiterated: Hold
Price Target: n/a
Current: $663.09
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $24.48
Upside: n/a
Jul 22, 2016
Rated: Buy
Price Target: n/a
Current: $41.10
Upside: n/a
Mar 17, 2015
Reiterated: Buy
Price Target: $23 → $56
Current: $0.9835
Upside: n/a